Hong Kong stock market volatility | Pharmaceutical stocks continue to strengthen in the morning session as domestic innovative drugs show strong momentum in going global. Hengrui Medicine is set to be listed on the Hong Kong stock market.

According to the Securities Times app, pharmaceutical stocks continued to perform strongly in the morning session. As of the time of publication, Laike Pharmaceuticals-B (02105.HK) rose by 12.38% to HK$16.88; CanSino Biologics-B (09966.HK) rose by 9.59% to HK$8.34; Ascentage Pharma-B (06855.HK) rose by 9.38% to HK$48.4; BrightGene (06127) rose by 7.28% to HK$10.9; and Junshi Biosciences (01877) rose by 7.14% to HK$16.8.